to liver microsteatosis. 5 As the liver plays a key role in both glucose and lipid metabolism, the above evidence suggests that the liver may be the key orchestrator of maternal smoking related substrate metabolic disorders in the offspring.
Previous studies suggest that female offspring are relatively protected from adverse in utero exposure. We have demonstrated that female offspring are protected from renal and neurological pathology induced by maternal SE in mice. [6] [7] [8] However, they still developed glucose intolerance at adulthood 2 , which is consistent with human studies. 1 Mattsson and colleagues demonstrated that women smoking during pregnancy increases their daughters' risk of developing obesity and gestational diabetes. 9 In addition, maternal smoking during the second trimester has been shown to change foetal liver markers involved in glucose metabolism in female children, which is clearly sex-specific. 10 Such changes may contribute to dysregulated glucose and lipid metabolism, and ultimately cardiovascular disease in adult females. As the critical organ for substrate metabolism, the influx of both dietary glucose and lipids in the liver can induce inflammatory responses resulting in insulin resistance and dysregulated lipid metabolism. 4 Chronic liver inflammation can also lead to fibrosis which can in turn affect liver function. 11 To date, the impact of maternal SE on liver makers of inflammation, substrate metabolism and fibrosis is unclear.
L-carnitine is an essential nutrient that serves as a biological cofactor involving in transporting long-chain fatty acid across the inner mitochondrial membrane for β-oxidation and ketones metabolism for energy production. 12 L-carnitine has also been shown to have an antiinflammatory effect in the liver of mice fed a high fat diet. 13 We have previously shown that L-carnitine supplementation during gestation and lactation in the SE dams can improve in utero cigarette smoke exposure-induced brain and renal pathology, as well as glucose intolerance at adulthood in the male offspring. 14, 15 Although female offspring from the SE dams are resistant to the development of neurological and renal pathologies, 7 they can still develop metabolic disorders such as glucose intolerance at adulthood. 2 Thus, this study aimed to evaluate the effect of maternal L-carnitine supplementation during gestation and lactation on glucose tolerance and liver markers involved in inflammation, substrate metabolism and fibrosis in the female offspring.
| RE SULTS

| Effect of cigarette smoke exposure on the mothers
The SE dams weighed least among the three groups prior to mating (P = 0.05 vs Sham) and had a trend to a lower weight when the pups were weaned (P = 0.08 vs Sham, Table S1 ). No difference was found in weight gain after gestation, litter size, or male and female numbers within the litter among the three dam groups (Table S1 ). Results are expressed as Mean ± SEM. n = 6-10. The data was analysed by One-way ANOVA followed by Turkey's post hoc tests. AUC, area under the curve; IPGTT, intraperitoneal glucose tolerance test; NEFA, Non-esterified fatty acids; TG, triglycerides. a P <.05 vs Sham; b P <.05 vs SE. P = .0001 vs SE). At 20 days (weaning age), the body weight and liver weight of the female offspring were not significantly affected by maternal SE; however, the body weight of the SE groups was 7.8%
| Body and blood parameters in the female mice offspring
lighter than the Sham group (Table 1) . Maternal SE increased the liver weight, expressed as a percentage of body weight, and random blood glucose levels (P = .04, Table 1 ). These parameters were normalised in the female SE + LC. At 13 weeks (mature age), body weight, liver weight, percentage of liver weight against body weight F I G U R E 1 Hepatic mRNA expression of inflammatory markers, (A, G) IL-1β, (B, H) IL-6, (C, I) IL-10, (D, J) IL-22, (E, K) TNF-α, and (F, L) TLR4 in the female offspring at 20 days and 13 weeks of age. Results are expressed as mean ± SEM, n = 6. *P < .05 SE vs Sham, # P < .05 SE + LC vs SE. IL, interleukin; SE, mother exposed to cigarette smoke; SE + LC, mother exposed to cigarette smoke and treated with L-carnitine during gestation and lactation; TLR, toll-like receptor and non-fasting blood glucose level were similar between the SE offspring and Sham offspring (Table 1) . Maternal L-carnitine supplementation decreased the percentage of liver weight/body weight in the female SE + LC offspring (P = .03, Table 1 ).
Plasma triglycerides (TG) levels were significantly increased in the female SE offspring compared to the Sham offspring at both 20 days (P = .004) and 13 weeks (P = .0007, Table 1 ). Plasma non-esterified fatty acids (NEFA) levels were not different among the three groups at any age. There was no difference in plasma insulin levels between the SE and Sham groups at 20 days, which showed a nearly 20% increase in the SE offspring at 13 weeks, although this was not statistically significant ( Table 1 ). The intraperitoneal glucose tolerance test (IPGTT) demonstrated an area under the curve (AUC) value in the SE offspring to be significantly higher than the Sham offspring at 12 weeks suggesting that the SE offspring are glucose intolerant (P = .008, Table 1 ).
Maternal L-carnitine treatment did not affect plasma insulin levels in the female offspring at any age. However, it normalised plasma TG levels at 20 days (P = .001 vs SE) and 13 weeks (P = .0007 vs SE), and AUC value in the SE + LC offspring (P = 0.02 vs SE + LC vs SE, Table 1 ).
| Inflammatory markers in the liver
At 20 days, IL-6 mRNA was tripled by maternal SE (P = .045 vs Sham, Figure 1B ). No differences were observed in the liver mRNA Results are mean ± SEM, n = 6. *P < .05 SE vs Sham , #P < .05 SE + LC vs SE. ATGL, adipose triglyceride lipase; CPT, carnitine palmitoyl transferase; FASN, fatty acid synthase gene; FOXO, forkhead box protein; PGC-1α, peroxisome proliferator-activated receptor gamma coactivator 1-alpha; PPAR, peroxisome proliferator-activated receptor; SE, mother exposed to cigarette smoke; SE + LC, mother exposed to cigarette smoke and treated with L-carnitine during gestation and lactation expression levels of the other pro-inflammatory markers including IL-1β, TNF-α and toll-like receptor (TLR)4 and anti-inflammatory markers IL-10 and IL-22 ( Figure 1 ). Maternal L-carnitine supplementation only showed a trend to increase the anti-inflammatory cytokine IL-10 (P = .07, SE vs SE + LC, Figure 1C ).
At 13 weeks, hepatic mRNA expression of IL-1β (P = .01, Figure 1G ) and TNF-α (P = .04, Figure 1K ) were upregulated compared with Sham, while the anti-inflammatory marker IL-10 (P = .01 vs Sham, Figure 1I ) was downregulated in the SE offspring compared to the Sham offspring. IL-6 expression was doubled (P = .08, Figure 1G ); while IL-22 was nearly halved (P = .43, Figure 1J ) in the female SE offspring, it did not reach statistical significance due to large variance. Maternal L-carnitine supplementation normalised liver IL-1β (P = .03 vs SE), IL-6 (P = .03 vs SE), IL-22 and TNF-α (P = .03 vs SE) mRNA expression ( Figure 1 ), while IL-10 mRNA expression was increased by around 40% in the SE + LC offspring compared with the SE offspring (P = .07 SE + LC vs SE by t-test, Figure 1I ). had a trend to be reduced by 57% (P = .08) and 54% (P = .06) respectively. Maternal SE had no effect on the mRNA levels of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), and Glut4 mRNA levels were not changed. Maternal L-carnitine F I G U R E 3 Hepatic fibrotic markers (A) collagen I and (B) collagen III staining quantification and representative photomicrographs of immunohistochemistry staining (mag 40×, scale bar = 50 μm) in the female offspring at 20 days and 13 weeks of age. Results are expressed as mean ± SEM, n = 6. *P < .05, * * P < .01, SE vs Sham; # P < .05, ## P < .01, SE + LC vs SE. SE, mother exposed to cigarette smoke; SE + LC, mother exposed to cigarette smoke and treated with L-carnitine during gestation and lactation supplementation normalised PGC1α (P = .04, SE + LC vs SE) and FASN mRNA expression (P = .38, SE + LC vs SE; Figure 2K ,L) caused by maternal SE, while Glut 4 mRNA expression in SE + LC offspring was less than half of the Sham and SE offspring albeit without statistical significance (P = .18, Figure 2G ).
| Substrate metabolic markers in the liver
forkhead
| Liver fibrosis
Cigarette smoking increases the risk of developing fibrosis in multiple organ systems. Both collagen I and III protein expression were more than doubled in the livers from the SE offspring at weaning (P = .0006 and P = .005 SE vs Sham, respectively; Figure 3A ,B). Both collagen I and III deposition in the SE + LC offspring was however normalised by maternal L-carnitine supplementation (collagen I, P = .005 SE + LC vs SE, Figure 3A ; collage III P = .0003, SE + LC vs SE, Figure 3B ).
At 13 weeks, although collagen I protein levels were not changed, collagen III protein expression was increased by nearly threefold in the SE offspring (P < .0001, SE vs Sham; Figure 3B ).
Maternal L-carnitine supplementation significantly reduced collagen I and III protein levels (collagen I, P = .0007 SE + LC vs SE; collagen III, P < .0001 SE + LC vs SE; Figure 3A ,B ).
| D ISCUSS I ON
Maternal SE prior to and during gestation and lactation significantly increased plasma lipid levels and caused glucose intolerance in the female offspring. This was associated with changes in liver lipid and glucose metabolic markers as well as increased fibrotic markers. The main finding in this study is that maternal L-carnitine supplementation during gestation and lactation can significantly ameliorate the adverse maternal SE impacts on glucose intolerance and hyperlipidaemia in the female offspring, which is linked to improved metabolic markers in the liver in addition to ameliorating liver collagen deposition.
This study showed an increase in the liver weight expressed as a percentage of total body weight at weaning in the female SE offspring. A similar trend was observed in their male littermates at adulthood. 6 This may reflect a catch up growth in less pivotal organs during development, which is commonly seen in the situation of intrauterine nutrition restriction such as maternal smoking. 1 The addictive substance nicotine has been suggested to play a major role, whereas details on how the other ~5000 chemicals in the cigarette smoke contribute to such effects individually are largely unknown.
In humans, there is a dose-dependent association between prenatal and postnatal SE and the development of insulin resistance, a risk factor for type 2 diabetes, in children as young as 10 years old. 16 As nicotine is transmittable via breastmilk during breastfeeding, neonatal nicotine exposure during lactation may cause insulin resistance and metabolic disorders at adulthood. 17 In this study, the female offspring from SE mothers developed glucose intolerance and hyperlipidaemia in adulthood. This is similar to the metabolic outcome in the male offspring at the same age, who had significant glucose intolerance albeit similar body weight as the controls.
14 Here at weaning, random blood glucose levels were also increased in the female SE offspring, followed by significantly increased glucose intolerance at adulthood, suggesting a continuous impairment in systemic glucose metabolism. Similar disorders in glucose metabolism have also been found in the male offspring from weaning to adulthood. 6, 14 It needs to be noted that in the laboratory setting, the rodent's diet is tightly controlled by using nutritionally balanced food, whereas in humans postnatal obesogenic/diabetogenic diet is an additional environment insult to the metabolic homeostatic regulation. Indeed, children of smokers tend to choose a high caloric diet which further accelerates the development of diabetes and related complications. 1 In this study, normal plasma insulin levels with hyperglycaemia in the female SE offspring at 20 days are suggestive of insulin resistance. Even at 13 weeks, plasma insulin levels were only marginally increased in the female offspring of SE dams (20%) compared to Sham offspring, with significant glucose intolerance; whereas in the male littermates, plasma insulin levels were similar to the control offspring. 14 Maternal nicotine exposure during gestation and lactation has been shown to induce permanent β-cell loss and subsequent impairment in glucose tolerance in animal models. 18 This may explain why there was no significant increase in blood insulin levels in both male and female SE offspring at adulthood. Furthermore, glucose intolerance at adulthood also indicates the insensitivity of insulin receptors. However, in a previous study we failed to observe a difference in the liver response to acute insulin stimulation. 2 Since exogenous insulin injection in that study was not as physiological as that released by the pancreas in the present study in response to postprandial glucose increase, this finding can't exclude the existence of liver insulin resistance. Previously, maternal supplementation of a mixture of antioxidant (vitamin E, coenzyme Q10 and α-lipoic acid) during pregnancy and lactation has been shown to increase beta cell proliferation and tissue insulin in offspring of nicotine treated rat mothers; however there were no measurements of either blood insulin level or glucose level in that study. 19 Inflammation may play a key role in maternal smoking induced glucose intolerance in the offspring. Maternal smoking has been shown to change liver inflammatory markers in male but not female foetuses in humans and rats. 10 Inflammation was also found to be increased in newborn livers from the mice of SE mothers, however livers from both sexes were combined in this study. 20 Here we showed significant increase in the liver inflammatory marker expression in female offspring at both weaning and adulthood. The association between insulin resistance, hyperglycaemia and increased liver inflammatory cytokine production (such as IL-1β and IL-6) has been well documented. 21 The mechanism is suggested to be via the inhibition of 2 essential markers involved in cellular glucose uptake, PPAR-γ and GLUT4. 22 PPAR-γ regulates glucose homeostasis and insulin sensitivity in a tissue and age dependent manner which also involves GLUT4, the insulin dependent glucose transporter. 23 TNF-α causes insulin resistance and glucose metabolic disorders through multiple mechanisms, including the downregulation of GLUT4, the inhibition on insulin signalling cascade, the stimulation of lipolysis to elevate free fatty acid level which induces insulin resistance, as well as the suppression of PPAR-γ expression and function. 22 Here, an upregulation of IL-6 with reduced PPAR-γ mRNA expression at weaning may initiate the development of insulin resistance leading to glucose intolerance at adulthood; whereas upregulated PPAR-γ at adulthood could be an adaptive response to glucose intolerance.
The anti-inflammatory cytokine IL-10 acts on macrophages to lower the pro-inflammatory cytokines such as TNF-α, and serum IL-10 is reduced in patients with insulin resistance. 24 Reduced IL-10 mRNA expression in the SE offspring at 13 weeks may suggest an attenuation of the anti-inflammatory capacity, in line with the upregulation of pro-inflammatory TNF-α and IL-1β. Another cytokine IL-22 has been reported to alleviate metabolic disorders, such as improving insulin sensitivity and lipid metabolism, decreasing chronic inflammation in the liver, and restoring postprandial glucose clearance in obese mice. 25 The trend reduction in IL-22 mRNA expression in the SE offspring at both ages also suggests a reduced capacity to counteract metabolic disorders. 25 Smoking is an independent risk factor for liver fibrosis due to cell injury induced by pro-inflammatory cytokines, such as IL-1, IL-6
and TNFα. 11 Here in adult female offspring, the increase in these pro-inflammatory cytokines were indeed accompanied by more collagen deposition. In this study, we found that liver collagen I and III proteins were increased in the SE offspring at 20 days, whereas only increased collagen III deposition occurred at adulthood.
FOXO1 interacts with PCG1α to suppress hepatic gluconeogenesis in response to insulin, whereas the mutation of FOXO1 can demolish such regulation. 26 FOXO1 mRNA expression was significantly reduced in weaning female offspring by maternal SE with increased blood glucose levels. FOXO1 expression was somewhat restored at 13 weeks when there was still significant glucose intolerance, suggesting that reduced tissue glucose uptake may play a major role.
Interestingly liver GLUT4 was somehow higher in the SE offspring, which was normalised by maternal L-carnitine treatment albeit improved glucose tolerance. This reflects the limitations of mRNA expression which does not reflect protein transcription. However, such upregulation may be an adaptive response to reduced protein levels, which explained increased AUC level during IPGTT. Therefore, the confirmation of protein levels and translocation in response to high glucose challenge is needed in future studies.
Smoking is a contributor to hypertriglyceridaemia in humans. 27 Our results showed that maternal SE during pregnancy and lactation led to increased plasma TG in female offspring. The exact mechanism for such effect is still unclear. The downregulation of regulators involved in lipid metabolism may play a key role. CPT-1α catalases the transportation of long-chain fatty acid into the mitochondria for oxidation to synthesise ATP; 28 while ATGL regulates liver TG turnover and free fatty acid β-oxidation. 29 PGC-1α is an essential metabolic switch for substrate metabolic functions, 30 which also promotes fatty acid oxidation. 31 Here both liver CPT-1α and ATGL mRNA expression is lower in the SE offspring at 20 days, which could potentially contribute to increased blood TG level. At 13 weeks, FASN was high in the female SE offspring, which may lead to increased de novo TG synthesis. This is consistent with a previous study using prenatal nicotine injection where FASN pathway was upregulated due to epigenetic modification. 32 The non-significant increase in PGC-1α can be an adaptive response to dysregulated glucose and lipid substrate metabolism.
We have previously demonstrated that maternal L-carnitine supplementation during gestation and lactation improves renal and neurological alterations in the male SE offspring of SE dams. 14, 15 In relation to the focus of this prior study, maternal L-carnitine supplementation also normalised low birth weight and kidney underdevelopment, as well as glucose intolerance in the male SE offspring in adulthood, 14 suggesting a beneficial effect on foetal development and metabolic outcome. In the present study, we demonstrated that maternal L-carnitine supplementation also ameliorated the effect of maternal SE on low birth weight and increased liver weight in the female offspring with normalised glucose homeostasis and lipid profile at adulthood. As such, these effects are similar between the male and female offspring from the SE mothers. The unchanged blood insulin level in both male and female offspring suggests that L-carnitine may improve peripheral insulin action, but not insulin production.
In humans, dietary L-carnitine supplementation has been shown to improve hepatic insulin resistance by decreasing TNF-α levels and improving lipid profiles; 33 The direct anti-inflammatory effect of Lcarnitine supplement has also been reported in a trial in patients with coronary artery disease. 34 Here in the female offspring, maternal L-carnitine supplementation had extended anti-inflammatory effects on their liver, evidenced by reduced levels of IL-1β, IL-6, and TNF-α expression in adulthood, all key players in insulin resistance.
Interestingly, suppression of the metabolic regulator IL-22 was also reversed in these female offspring by maternal L-carnitine supplementation, which may contribute to normalised pro-inflammatory cytokines and glucose metabolism. Previously, L-carnitine has been shown to prevent the development of fibrosis in multiple organs, including the liver, 35 as well as ameliorate alcohol-induced liver damage. 36 In this study, maternal L-carnitine supplementation suppressed or normalised liver collagen deposition in the weaning and adult female offspring. It needs to be noted that the liver contains a low percentage of collagen -in the order of less than 4%. A second insult that promotes fibrosis such as viral hepatitis or non-alcoholic fatty liver disease is required to further determine whether offspring of SE dams are linked to high risk of liver cirrhosis, and whether maternal L-carnitine supplementation can prevent such changes.
Maternal L-carnitine supplementation normalised blood lipid profiles in the female SE offspring at both 20 days and 13 weeks.
In rats fed a high fat diet, L-carnitine was shown to reduce liver TG synthesis and/or release, 37 as well as improve lipid β-oxidation. 38 In this study, maternal L-carnitine nearly normalised the TG lipase 
| ME THODS
| Animal model
The animal experiments were approved by the Animal Care 
| Intraperitoneal glucose tolerance test (IPGTT)
IPGTT was performed at 12 weeks of age. After 5 hours fasting, a baseline glucose level was taken from the tail blood (Accu-Chek, Roche Diagnostics, Indianapolis, IN, USA). Then the glucose was administered (2 g/kg, n = 9-10, ip) and blood glucose levels were measured at 15, 30, 60, and 90 minutes post-injection as previously described. 2 The area under the curve (AUC) of the glucose levels was calculated for each mouse.
| Bio-assays
Plasma TG, NEFA and insulin concentrations were measured using an in-house TG assay (TG reagent, Roche Diagnostics, Mannheim, Germany; intra-assay variation 0.5%, inter-assay variation 3.4%),
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NEFA-HR kit (WAKO, Osaka; Japan, intra-assay variation 0.75%, inter-assay variation 4.91%), and Insulin ELISA Kit (Abnova, Taipei, Taiwan; intra-and inter-assay variation 2.2% and 5.0%, respectively).
| Real-time PCR
Total RNA was extracted from liver tissues using RNeasy plus mini kit (Qiagen, Valencia, CA) according to the manufacturers' instructions.
The first strand of cDNA was synthesised from RNA using Transcriptor First Strand cDNA Synthesis Kit (Roche Diagnostics, Mannheim, Germany). The genes of interest were measured using manufacturer pre-optimized and validated TaqMan primers and probes (Table S1 
| Immunohistochemistry
For direct visualisation of collagen fibres, formalin fixed livers were embedded in paraffin and sectioned to 5 μm. Three nonconsecutives sections were collected from each sample (n = 6/group).
Immunohistochemistry was performed with the Dako EnVision+
System-HRP labelled Polymer Anti-Rabbit kit (Agilent, Santa Clara, CA, USA). In brief, the sections were deparaffinised and treated with xylene 
| Statistical analysis
The results are expressed as mean ± SEM. The differences between the groups were analysed using one-way ANOVA followed by Turkey's post hoc tests (Prism 6, Graphpad, San Jose, CA, USA).
Student's unpaired t-test was used for selected two groups with marked difference. P < .05 is considered significant. 
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